| Otanthia S Williams-brady, APN | |
|
2160 S 1st Ave, Maywood, IL 60153-3328 | |
| (708) 327-2181 | |
| (708) 327-2424 |
| Full Name | Otanthia S Williams-brady |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 2160 S 1st Ave, Maywood, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134731375 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 209.021711 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Loyola University Medical Center | Maywood, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Loyola University Medical Center | 3779488903 | 863 |
News Archive
A clinical trial called HVTN 100 has been launched in South Africa to study an investigational HIV vaccine regimen for safety and the immune responses it generates in study participants. This experimental vaccine regimen is based on the one tested in the U.S. Military HIV Research Program-led RV144 clinical trial in Thailand-the first study to demonstrate that a vaccine can protect people from HIV infection.
Neurocrine Biosciences, Inc. announced today that it has recently completed subject randomization of the Phase III clinical trial (Kinect 3 Study) of its proprietary Vesicular Mono-Amine Transporter 2 (VMAT2) compound NBI-98854 in tardive dyskinesia patients.
Despite a low likelihood of positive results, children who develop fever in the first two days after surgery are often subjected to non-targeted, costly and invasive testing. This is according to a study that was recently published in the Journal of Pediatric Surgery.
The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).
› Verified 8 days ago
| Entity Name | Loyola University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336159961 PECOS PAC ID: 3779488903 Enrollment ID: O20031202000027 |
News Archive
A clinical trial called HVTN 100 has been launched in South Africa to study an investigational HIV vaccine regimen for safety and the immune responses it generates in study participants. This experimental vaccine regimen is based on the one tested in the U.S. Military HIV Research Program-led RV144 clinical trial in Thailand-the first study to demonstrate that a vaccine can protect people from HIV infection.
Neurocrine Biosciences, Inc. announced today that it has recently completed subject randomization of the Phase III clinical trial (Kinect 3 Study) of its proprietary Vesicular Mono-Amine Transporter 2 (VMAT2) compound NBI-98854 in tardive dyskinesia patients.
Despite a low likelihood of positive results, children who develop fever in the first two days after surgery are often subjected to non-targeted, costly and invasive testing. This is according to a study that was recently published in the Journal of Pediatric Surgery.
The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Otanthia S Williams-brady, APN 2160 S 1st Ave, Maywood, IL 60153-3328 Ph: (708) 216-9122 | Otanthia S Williams-brady, APN 2160 S 1st Ave, Maywood, IL 60153-3328 Ph: (708) 327-2181 |
News Archive
A clinical trial called HVTN 100 has been launched in South Africa to study an investigational HIV vaccine regimen for safety and the immune responses it generates in study participants. This experimental vaccine regimen is based on the one tested in the U.S. Military HIV Research Program-led RV144 clinical trial in Thailand-the first study to demonstrate that a vaccine can protect people from HIV infection.
Neurocrine Biosciences, Inc. announced today that it has recently completed subject randomization of the Phase III clinical trial (Kinect 3 Study) of its proprietary Vesicular Mono-Amine Transporter 2 (VMAT2) compound NBI-98854 in tardive dyskinesia patients.
Despite a low likelihood of positive results, children who develop fever in the first two days after surgery are often subjected to non-targeted, costly and invasive testing. This is according to a study that was recently published in the Journal of Pediatric Surgery.
The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).
› Verified 8 days ago
Dr. Margaret Mary Naber, DNP, APRN, NNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Bldg 101, Room 1752, Maywood, IL 60153 Phone: 708-216-9000 Fax: 708-216-6269 | |
Ms. Victoria Anne Davidson-bell, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-6569 | |
Ijeoma Achebe, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-9000 | |
Mrs. Camille Kidd Moses, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-8591 Fax: 708-218-8600 | |
Lauren M Martin, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-9000 | |
Ms. Emily Wang, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Nancy Pak, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Ems 110, Maywood, IL 60153 Phone: 708-216-9000 |